Article info
Commentary
Targeting of gut specific leucocyte recruitment in IBD by vedolizumab
- Correspondence to Dr Bertus Eksteen, Division of Gastroenterology and Hepatology, Snyder Institute for Chronic Diseases, Health Research and Innovation Centre (HRIC), University of Calgary, 4AC66—3280 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1; b.eksteen{at}ucalgary.ca
Citation
Targeting of gut specific leucocyte recruitment in IBD by vedolizumab
Publication history
- Received May 28, 2014
- Revised May 30, 2014
- Accepted June 2, 2014
- First published June 19, 2014.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions